drugset / Trial / NCT00645424

A Study To Evaluate The Safety And Efficacy Of Atorvastatin In Patients With Diabetes And High Cholesterol

NCT00645424 ↗

Phase 4 Completed 155 enrolled Viatris Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of atorvastatin for the treatment of Taiwanese patients with diabetes and high cholesterol.

Timeline

Start
2003-12
Primary completion
—
Completion
2004-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 10 mg Oral
Subject Atorvastatin Small molecule 20 mg Oral
Subject Atorvastatin Small molecule 40 mg Oral

Indications